Amaia Ercilla
Bilbao, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 21, 2026
Correction: The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: July 22, 2025
A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.
Journal: Molecular oncology
Published: April 16, 2025
Aggressive prostate cancer is associated with pericyte dysfunction.
Journal: Molecular oncology
Published: February 15, 2025
USP29-regulated noncanonical stabilization of the hypoxia-inducible factor-α in aggressive prostate cancer.
Journal: Molecular oncology
Published: November 13, 2024
Syndecan-3 positively regulates the pro-inflammatory function of macrophages.
Journal: Cellular and molecular life sciences : CMLS
Published: August 08, 2024
Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 23, 2024
The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: December 21, 2023
RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress.
Journal: PloS one
Published: March 22, 2022
Nanocomposite Scaffolds for Monitoring of Drug Diffusion in Three-Dimensional Cell Environments by Surface-Enhanced Raman Spectroscopy.
Journal: Nano letters
Published: October 06, 2021
Last Updated: 09/26/2026